Aruna Bansal
- U-BIOPRED: Clinical characteristics of children with severe asthma (SA) and severe pre-school wheeze (SPSW)By Louise Fleming, Ana Sousa, Clare Murray, Simone Hashimoto, Gunilla Hedlin, Julie Corfield, Rowe Anthony, Florian Singer, Urs Frey, Hans Bisgaard, Andrew Bush, Scot Wagers, Kian Fan Chung, Dominick Shaw, Stephen Fowler, Ioannis Pandis, Christopher Compton, Wolfgang Seibold, Aruna Bansal, Peter Sterk and Graham RobertsLouise Fleming1NHLI, Imperial College, London, United Kingdom12Respiratory Medicine, Royal Brompton Hospital, London, United KingdomAna Sousa2Discovery Medicine, GSK, London, United KingdomClare Murray3Respiratory Medicine, University of Manchester, Manchester, United KingdomSimone Hashimoto4Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsGunilla Hedlin5Respiratory Medicine, Karolinska Institute, Stockholm, SwedenJulie Corfield6R and D, Areteva, Nottingham, United Kingdom10R and D, AstraZeneca, Mölndal, SwedenRowe Anthony7R and D IT, Janssen Research and Development, London, United KingdomFlorian Singer8Respiratory Paediatrics, Inselspital and University of Bern, Bern, Switzerland9Paediatrics, University Children's Hospital Zurich, Zurich, SwitzerlandUrs Frey8Respiratory Paediatrics, Inselspital and University of Bern, Bern, SwitzerlandHans Bisgaard11Paediatrics, Copenhagen University Hospital, Copenhagen, DenmarkAndrew Bush1NHLI, Imperial College, London, United Kingdom12Respiratory Medicine, Royal Brompton Hospital, London, United KingdomScot Wagers13Managing Director, BioSci Consulting, Maasmechelen, BelgiumKian Fan Chung1NHLI, Imperial College, London, United Kingdom12Respiratory Medicine, Royal Brompton Hospital, London, United KingdomDominick Shaw14Respiratory Medicine, Universoty of Nottingham, Nottingham, United KingdomStephen Fowler3Respiratory Medicine, University of Manchester, Manchester, United KingdomIoannis Pandis1NHLI, Imperial College, London, United KingdomChristopher Compton15Respiratory Development, Novartis Pharma AG, Horsham, United KingdomWolfgang Seibold16Respiratory Medicine, Boehringer Ingelheim Pharma GmbH & Co, Ingelheim, GermanyAruna Bansal17Statistical Genetics, Acclarogen, Cambridge, United KingdomPeter Sterk4Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsGraham Roberts18Respiratory Paedaitrics and Allergy, University of Southampton, Southampton, United Kingdom
- Combined analysis of gene expression and clinical data in the severe asthma U-BIOPRED cohortsBy Bertrand De Meulder, Diane Lefaudeux, Mansoor Saqi, Charles Auffray, Ian Adcock, Fan Chung, Jeanette Bigler, Matthew Loza, Navin Rao, Anthony Rowe, Frédéric Baribaud, Graham Roberts, Ana Sousa, Aruna Bansal, Chris Compton, David Myles, Ratko Djukanovic, Dominic Shaw, Ildiko Horvath, Jacek Musial, Julie Corfield, Pascal Chanez, Norbert Krug, Paolo Montuschi, Per Bakke, Peter Sterk, Riccardo Polosa, Scott Wager, Florian Singer, Stephen Fowler, Sven-Erik Dahlen, Thomas Sandström, Timothy Higenbottam, Ulf Nihlén, Urs Frey and Wolfgang SeiboldBertrand De Meulder1EISBM, CNRS, Lyon, Rhone, FranceDiane Lefaudeux1EISBM, CNRS, Lyon, Rhone, FranceMansoor Saqi1EISBM, CNRS, Lyon, Rhone, FranceCharles Auffray1EISBM, CNRS, Lyon, Rhone, FranceIan Adcock2National Heart & Lung Institute, Imperial College London, London, United KingdomFan Chung2National Heart & Lung Institute, Imperial College London, London, United KingdomJeanette Bigler3Amgen Inc, Amgen Inc, Seattle,Matthew Loza4Janssen Research and Development, Janssen, Springhouse,Navin Rao4Janssen Research and Development, Janssen, Springhouse,Anthony Rowe4Janssen Research and Development, Janssen, Springhouse,Frédéric Baribaud4Janssen Research and Development, Janssen, Springhouse,Graham Roberts5University Hospital Southampton NHS Foundation Trust, NHS Foundation Trust, Southampton, United KingdomAna Sousa6Discovery Medicine, GlaxoSmithKline, Uxbridge, United KingdomAruna Bansal7Acclarogen, Acclarogen Ltd, Cambridge, United KingdomChris Compton8Respiratory Development, Novartis, Redhill, United KingdomDavid Myles6Discovery Medicine, GlaxoSmithKline, Uxbridge, United KingdomRatko Djukanovic5University Hospital Southampton NHS Foundation Trust, NHS Foundation Trust, Southampton, United KingdomDominic Shaw9Nottingham University Hospital, Nottingham University Hospital, Nottingham, United KingdomIldiko Horvath10Semmelweis University, Semmelweis University, Budapest, HungaryJacek Musial11Allergy and Immunology, Jagiallonian University, Krakow, PolandJulie Corfield12Areteva, Areteva Ltd, Nottingham, United KingdomPascal Chanez13Clinique des Bronches, Allergie et Sommeil, Université de la Méditerranée, Marseille, FranceNorbert Krug14Immunology, Allergology and Clinical Inhalation, Fraunhofer Institute, Hannover, GermanyPaolo Montuschi15Pharmacology, Università Cattolica del Sacro Cuore, Roma, ItalyPer Bakke16Thoracic Medicine, Haukeland University Hospital, Bergen, SwedenPeter Sterk17Pulmonology, Academisch Medisch Centrum, Amsterdam, NetherlandsRiccardo Polosa18Internal Medicine and Clinical Immunology, University of Catania, Catania, ItalyScott Wager19BioSci Consulting, BioSci Consulting, Maasmechelen, BelgiumFlorian Singer20Paediatric Respiratory Medicine, University Hospital, Inselpital, Bern, SwitzerlandStephen Fowler21Respiratory Research Group, University of Manchester, Manchester, United KingdomSven-Erik Dahlen22Experimental Asthma and Allergy Research, Karolinska Institutet, Stockholm, SwedenThomas Sandström23Pulmonology, University Hospital, Umea, SwedenTimothy Higenbottam24Corporate Clinical Development, Chiesi Pharmaceutics Ltd, Cheadle, United KingdomUlf Nihlén25AstraZeneca R&D, AstraZeneca, Södertälje, SwedenUrs Frey20Paediatric Respiratory Medicine, University Hospital, Inselpital, Bern, SwitzerlandWolfgang Seibold26Boehringer Ingelheim, Boehringer Ingelheim Corporation, Ingelheim am Rhein, Germany
- Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortiumBy A.R. Sousa, Ioannis Pandis, Yang Xian, Uruj Hoda, Anthony Rowe, Julie Corfield, Elizabeth Jeyasingham, Aruna Bansal, Wolfgang Seibold, Ariane Wagener, Per Bakke, Graham Roberts, Florian Singer, Urs Frey, Horváth Ildikó, Riccardo Polosa, Norbert Krug, Roelinde Middelveld, Sven-Erik Dahlen, Jacek Musial, David Gibeon, Louise Fleming, Stephen Fowler, Laurie Pahus, Dominic Shaw, Peter Howarth, David Myles, Chris Compton, Tim Higenbottam, Paolo Montuschi, Jorgen Vestbo, Ulf Nihlen, Thomas Sandström, Scott Wagers, Ratko Djukanovic, Elisabeth Bel, Peter Sterk and Fan ChungA.R. Sousa1Discovery Medicine, GlaxoSmithKline, London, United KingdomIoannis Pandis2NHLI and Discovery Sciences, Imperial College, London, United KingdomYang Xian2NHLI and Discovery Sciences, Imperial College, London, United KingdomUruj Hoda2NHLI and Discovery Sciences, Imperial College, London, United KingdomAnthony Rowe5R&D IT External Innovation, Janssen, San Diego,Julie Corfield4Biobanking, AstraZeneca, Nottingham, United KingdomElizabeth Jeyasingham1Discovery Medicine, GlaxoSmithKline, London, United KingdomAruna Bansal23Biostatistics, Acclarogen Ltd, Cambridge, United KingdomWolfgang Seibold20Pharmaceuticals, Boehringer Ingelheim, Ingelheim, GermanyAriane Wagener9Faculty of Medicine, Universiteit van Amsterdam, Amsterdam, NetherlandsPer Bakke18Department of Medicine, Universitetet i Bergen, Bergen, NorwayGraham Roberts3Respiratory Medicine, University of Southampton, Southampton, United KingdomFlorian Singer16Division of Paediatric Respiratory Medicine, University Hospital, Inselspital, Bern, SwitzerlandUrs Frey16Division of Paediatric Respiratory Medicine, University Hospital, Inselspital, Bern, SwitzerlandHorváth Ildikó13Department of Pulmonology, Semmelweis University, Budapest, HungaryRiccardo Polosa15Institute of Internal Medicine and Clinical Immunology, University of Catania, Catania, ItalyNorbert Krug14Department of Clinical Airway Research, Fraunhofer-Gesellschaft, Hamburg, GermanyRoelinde Middelveld22BioSci Consulting, BioSci Consulting, Maasmechelen, BelgiumSven-Erik Dahlen22BioSci Consulting, BioSci Consulting, Maasmechelen, BelgiumJacek Musial7Department of Medicine, Jagiellonian University, Krakow, PolandDavid Gibeon2NHLI and Discovery Sciences, Imperial College, London, United KingdomLouise Fleming2NHLI and Discovery Sciences, Imperial College, London, United KingdomStephen Fowler8Respiratory Research Group, University of Manchester, Manchester, United KingdomLaurie Pahus10Département des Maladies Respiratoires, Université de la Méditeranée Aix-Marseille II, Marseille, FranceDominic Shaw17Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, United KingdomPeter Howarth3Respiratory Medicine, University of Southampton, Southampton, United KingdomDavid Myles1Discovery Medicine, GlaxoSmithKline, London, United KingdomChris Compton6Pharmaceuticals, Novartis, Basel, SwitzerlandTim Higenbottam22BioSci Consulting, BioSci Consulting, Maasmechelen, BelgiumPaolo Montuschi11Facoltà di Medicina e Chirurgia, Universita Cattolica Del Sacro Cuore, Roma, ItalyJorgen Vestbo12Department of Respiratory Medicine, Hvidore Hospital, Hvidovre, DenmarkUlf Nihlen4Biobanking, AstraZeneca, Nottingham, United KingdomThomas Sandström19Pulmonary Medicine, Umeå University, Umeå, SwedenScott Wagers22BioSci Consulting, BioSci Consulting, Maasmechelen, BelgiumRatko Djukanovic3Respiratory Medicine, University of Southampton, Southampton, United KingdomElisabeth Bel9Faculty of Medicine, Universiteit van Amsterdam, Amsterdam, NetherlandsPeter Sterk9Faculty of Medicine, Universiteit van Amsterdam, Amsterdam, NetherlandsFan Chung2NHLI and Discovery Sciences, Imperial College, London, United Kingdom
- The U-BIOPRED severe asthma study: Immunopathological characterisationBy Susan Wilson, Jonathan Ward, Ana Sousa, Julie Corfield, Aruna Bansal, Peter Sterk, Fan Chung, Ratko Djukanovic, Sven-Erik Dahlen, Pascal Chanez, Dominick Shaw, Norbert Krug, Thomas Sandström, Peter Howarth and U-BIOPRED ConsortiumSusan Wilson1Faculty of Medicine, University of Southampton, Southampton, United KingdomJonathan Ward1Faculty of Medicine, University of Southampton, Southampton, United KingdomAna Sousa2Respiratory Therapy Unit, GlaxoSmithKline, Uxbridge, United KingdomJulie Corfield3R&D, AstraZeneca, Molondal, Sweden4R&D, Areteva, Nottingham, United KingdomAruna Bansal5Statistical Genetics, Acclarogen, Cambridge, United KingdomPeter Sterk6Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsFan Chung7National Heart and Lung Institute, Imperial College London, London, United KingdomRatko Djukanovic1Faculty of Medicine, University of Southampton, Southampton, United KingdomSven-Erik Dahlen8Centre for Allergy Research, Karolinska Institute, Stockholm, SwedenPascal Chanez9Department of Respiratory Medicine, Université de la Médierranee, Marseille, FranceDominick Shaw10Centre for Respiratory Research, University of Nottingham, Nottingham, United KingdomNorbert Krug11Clinical Research Centre, Fraunhofer Institute of Toxicology & Experimental Medicine, Hannover, GermanyThomas Sandström12Department of Respiratory Medicine, Umea University, Umea, SwedenPeter Howarth1Faculty of Medicine, University of Southampton, Southampton, United KingdomU-BIOPRED Consortium1Faculty of Medicine, University of Southampton, Southampton, United Kingdom
- Characteristics of the frequent exacerbator in U-BIOPRED adult severe asthma cohortBy Uruj Hoda, Ana Sousa, Julie Corfield, Dominic Shaw, Stephen Fowler, Louise Fleming, Wolfgang Seibold, Per Bakke, Christophe Von Garnier, Ildikó Horváth, Norbert Krug, Barbro Dahlen, Jacek Musial, Pascal Chanez, Paolo Montuschi, Thomas Sandstrom, Peter Howarth, Elisabeth Bel, Aruna Bansal, Ioannis Pandis, Chih-Hsi Kuo, Ratko Djukanovic, Peter Sterk, Graham Roberts, Fan Chung, Fan Chung and U-BIOPRED Study GroupUruj Hoda1NHLI, Imperial College London, London, United KingdomAna Sousa2Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomJulie Corfield3Clinical Research, AstraZeneca, Mölndal, SwedenDominic Shaw4Nottingham Respiratory Research Unit, Nottingham City Hospital, Nottingham, United KingdomStephen Fowler5Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomLouise Fleming1NHLI, Imperial College London, London, United KingdomWolfgang Seibold6Global Clinical Operations, Boehringer Ingelheim Pharma GmbH & Co. KG, 8Global Clinical Operations, Boehringer Ingelheim, Ingelheim am Rhein GermanyPer Bakke8Respiratory, Haukeland University Hospital, Bergen, NorwayChristophe Von Garnier9Respiratory, Inselspital and University of Bern, Bern, SwitzerlandIldikó Horváth10Department of Pulmonology, Semmelweis University, Budapest, HungaryNorbert Krug11Medicine, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, GermanyBarbro Dahlen12The Centre for Allergy Research, Karolinska Institute, Stockholm, SwedenJacek Musial13Medical College, Jagiellonian University, Krakow, PolandPascal Chanez14Hopital Nord, Bureau de Recherche Clinique, Université de la Méditerranee, Marseille, FrancePaolo Montuschi15Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, ItalyThomas Sandstrom16Respiratory and Allergy Division, University Hospital, Umeå, Umeå, SwedenPeter Howarth7Faculty of Medicine, University of Southampton, Southampton, United KingdomElisabeth Bel17Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsAruna Bansal18Acclarogen, Acclarogen Ltd, Cambridge, United KingdomIoannis Pandis1NHLI, Imperial College London, London, United KingdomChih-Hsi Kuo1NHLI, Imperial College London, London, United KingdomRatko Djukanovic7Faculty of Medicine, University of Southampton, Southampton, United KingdomPeter Sterk17Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsGraham Roberts7Faculty of Medicine, University of Southampton, Southampton, United KingdomFan Chung1NHLI, Imperial College London, London, United KingdomFan Chung1NHLI, Imperial College London, London, United Kingdom1NHLI, Imperial College London, London, United Kingdom
- Exhaled breath VOCs are associated with nocturnal wakening in asthmatic childrenBy Yuanyue Wang, Simone Hashimoto, Paul Brinkman, Teunis J. Vink, Hans Weda, Hugo Knobel, Tamara Nijsen, Nicholas J.W. Rattray, Paolo Montuschi, Marco Santonico, Giorgio Pennazza, Arnaldo D'Amico, Louise Fleming, Ana R. Sousa, Clare Murray, Julie Corfield, Hans Bisgaard, Andrew Bush, Wim Van Aalderen, Fan Chung, Dominic Shaw, Ioannis Pandis, Aruna Bansal, Graham Roberts, Peter J. Sterk and Stephen FowlerYuanyue Wang1Philips Research, Philips, Eindhoven, NetherlandsSimone Hashimoto2Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsPaul Brinkman2Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsTeunis J. Vink1Philips Research, Philips, Eindhoven, NetherlandsHans Weda1Philips Research, Philips, Eindhoven, NetherlandsHugo Knobel1Philips Research, Philips, Eindhoven, NetherlandsTamara Nijsen1Philips Research, Philips, Eindhoven, NetherlandsNicholas J.W. Rattray3Manchester Institute of Biotechnology, University of Manchester, Manchester, United KingdomPaolo Montuschi4Faculty of Medicine, Catholic University of the Sacred Heart, Rome, ItalyMarco Santonico5CIR Center for Integrated Research, Unit of Electronics for Sensor Systems, University Campus Bio-Medico di Roma, Rome, ItalyGiorgio Pennazza5CIR Center for Integrated Research, Unit of Electronics for Sensor Systems, University Campus Bio-Medico di Roma, Rome, ItalyArnaldo D'Amico6Department of Electronic Engineering, University of Rome Tor Vergata, Rome, ItalyLouise Fleming7Department of Respiratory Paediatrics, National Heart & Lung Institute, Imperial College London, London, United KingdomAna R. Sousa8Clinical Development, Respiratory Therapy Unit, GSK, London, United KingdomClare Murray9Manchester Academic Health Science Centre, NIHR Translational Research Facility in Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomJulie Corfield10Areteva Ltd, AstraZeneca R&D, Mölndal, S & Areteva Ltd, Nottingham, United KingdomHans Bisgaard11Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Copenhagen University Hospital Gentofte, Copenhagen, DenmarkAndrew Bush7Department of Respiratory Paediatrics, National Heart & Lung Institute, Imperial College London, London, United KingdomWim Van Aalderen15Dept of Pediatric Respiratory Medicine and Allergy, Emma Children's Hospital AMC, Amsterdam, NetherlandsFan Chung7Department of Respiratory Paediatrics, National Heart & Lung Institute, Imperial College London, London, United KingdomDominic Shaw12Faculty of Medicine & Health Sciences, Nottingham City Hospital, Nottingham, United KingdomIoannis Pandis16Data Science Institute / Discovery Sciences Group, Imperial College London, London, United KingdomAruna Bansal13Biostatistics, Acclarogen, Cambridge, United KingdomGraham Roberts14Clinical and Experimental Allergy and Southampton NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United KingdomPeter J. Sterk2Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsStephen Fowler9Manchester Academic Health Science Centre, NIHR Translational Research Facility in Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
